European Pharmaceutical Review

NOVEMBER 9, 2023

Stenico looks at the potential expansion of biosimilars in Europe, explaining how creating a sustainable procurement process, that goes beyond price-based tendering, will be key to realising their potential. When it comes to biologics, scaling up production to ensure global supply is a remarkable process that embodies Industry 4.0

Pharmaceutical 83

Pharmaceutical Manufacturing Medicine Management 83

Cesare Ferrari

OCTOBER 22, 2023

I recently met an ex-colleague and we discussed for a couple of hours several decisions made by the management of a MedTech company that we both felt were not focused on the customer. Moreover, Bain and Company, Inc.’s 6 Ingredients for developing customer orientation    1.Establish 6 Ingredients for developing customer orientation    1.Establish

Medical 52

Medical Sales Doctors Management 52

Pharmaceutical Technology

JULY 15, 2022

California’s budget documents give few details about the tender process, but state that CalRx will spend $50 million to partner with a contract manufacturer to develop biosimilar insulin products in vial and pen form. Most of the US insulin market is controlled by three pharma companies: Sanofi, Eli Lilly, and Novo Nordisk.

Manufacturing 131

Manufacturing Insurance Pharmaceutical Marketing 131

pharmaphorum

JULY 20, 2022

As industry raises concerns about the multiple ways spend is managed – unsaid but pointing to a big squeeze on drug spending – she argues that industry will need to put together a strong evidence-based case to achieve change. With NHS England highlighting savings of £1.2 Savings on medicines make the headlines.

Medicine 52

Medicine Sales Ethics Marketing 52

pharmaphorum

JANUARY 9, 2023

Higher income countries will also pursue plans to localise in 2023: Germany wants statutory health insurers to consider local production for drugs in tenders to prefer reliable European manufacturers, and the EU medicines strategy in March 2023 will ensure a future-proof and resilient system, reducing the EU’s dependency on third party countries.

Medicine 82

Medicine Healthcare Healthcare Pharma 82

Pharmaceutical Technology

MAY 23, 2023

According to the NPF, the function of its joint tender agreement is not limited to ensuring lower prices and security of supply. Rather, the collaborative framework is also intended to help the region develop on its “green agenda” through the inclusion of environmental criteria, particularly when tendering for older, off-patent medicines.

Medicine 52

Medicine Distribution Pharma Pharmaceutical 52

Pharmaceutical Technology

FEBRUARY 28, 2023

The Commercial Partnerships division within Abacus Medicine Pharma Services has supported pharmaceutical partners in the successful European launch of a range of orphan drug assets, with particularly valuable expertise in key markets outside of the EU-5 such as BENELUX and the Nordics.

Medicine 52

Medicine Distribution Marketing Pharmaceutical 52